Pharmaceuticals

Growing Demand For Pharmaceuticals Is Fueling The Market Growth Due To Increasing Need For High-Purity Excipients In Drug Formulations Is Supporting Development Across The Pharma Grade Calcium Sulphate Market

May 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Expected Market Size Of The Pharma Grade Calcium Sulphate Market In 2026 And How Much Will It Reach By 2030?

The pharma grade calcium sulphate market has demonstrated significant expansion in recent years. Its valuation is set to increase from $0.96 billion in 2025 to $1.04 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.5%. This past growth is largely attributable to factors such as the expansion in pharmaceutical manufacturing, a higher demand for solid dosage forms, the widening production of generic drugs, the increasing utilization of calcium-based excipients, and a stronger regulatory focus on excipient quality.

The pharma grade calcium sulphate market size is projected to experience substantial growth in the upcoming years. It is anticipated to achieve a value of $1.44 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.4%. This projected growth can be linked to factors such as the expansion of global drug production, the increasing adoption of high-performance excipients, a rising requirement for consistent formulation quality, the growth in nutraceutical manufacturing, and improvements in excipient processing. Significant trends for this forecast period include an elevated demand for high-purity pharmaceutical excipients, their increasing application in tablet and capsule formulations, greater utilization in calcium supplement production, the expansion of quality-controlled excipient manufacturing, and a concentrated effort on regulatory-compliant materials.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24372&type=smp

What Influential Factors Are Boosting The Pharma Grade Calcium Sulphate Market Demand?

The market for pharma grade calcium sulphate is projected to expand significantly due to the increasing demand for pharmaceuticals. Pharmaceuticals encompass drugs and medical treatments created, produced, and utilized for disease diagnosis, treatment, or prevention in both human and animal populations. This escalating demand for pharmaceuticals stems largely from the increasing incidence of chronic illnesses, which necessitates long-term drug regimens for managing conditions like diabetes, cardiovascular diseases, and cancer in a greater number of people. Pharma grade calcium sulphate improves pharmaceutical formulations, functioning as a high-purity excipient essential for maintaining uniform tablet hardness, stability, and regulated release of active components. As an example, Eurostat, the European Union’s official statistical agency located in Luxembourg, reported in April 2024 that medicinal and pharmaceutical product imports into the EU rose by 6.1% in 2023, reaching a total of $137.4 billion (€119 billion) when compared to the prior year. Concurrently, EU exports for the same period amounted to $319.2 billion (€277 billion), leading to a trade surplus of $182.0 billion (€158 billion). Consequently, the expanding need for pharmaceuticals is a key factor propelling the growth of the pharma grade calcium sulphate market.

What Are The Core Segment Classifications In The Pharma Grade Calcium Sulphate Market?

The pharma grade calcium sulphate market covered in this report is segmented –

1) By Type: Calcium Sulphate Dihydrate, Calcium Sulphate Hemihydrate, Calcium Sulphate Anhydrite

2) By Application: Pharmaceutical Excipients, Binders In Tablet Formulations, Calcium Supplements, Diagnostic Agents

3) By Distribution Channel: Direct Distribution, Online Distribution, Wholesale Distribution, Retail Distribution

Subsegments:

1) By Calcium Sulphate Dihydrate: Fine Powder, Granular Form, Micronized Grade

2) By Calcium Sulphate Hemihydrate: Alpha Hemihydrate, Beta Hemihydrate, High Purity Hemihydrate

3) By Calcium Sulphate Anhydrite: Natural Anhydrite, Synthetic Anhydrite, High-Density Anhydrite

Which Trends Are Expected To Shape The Pharma Grade Calcium Sulphate Market?

Leading firms within the pharma grade calcium sulphate market are concentrating on creating novel products, leveraging synthetic medical-grade bassanite to improve the purity and uniformity of calcium sulphate offerings. Synthetic medical-grade bassanite, defined as a highly pure, partially dehydrated calcium sulphate (CaSO4·0.5H2O), facilitates the production of pharma-grade calcium sulphate by supplying a reliable, uncontaminated raw material that adheres to rigorous regulatory criteria for medical and pharmaceutical uses. An example of this is the launch in February 2025 by Sree Chitra Tirunal Institute for Medical Sciences & Technology, an India-based medical institute, of Caspro & Bonyx. These are groundbreaking drug-eluting bone graft products, created with synthetic medical-grade bassanite to guarantee superior purity, biocompatibility, and precise drug release for sophisticated orthopedic uses. Caspro is a self-curing, malleable bone cement derived from calcium sulfate hemihydrate, strengthened with phosphate ions, making it perfect for repairing bone deficiencies and releasing medications locally for more than 21 days. Bonyx, on the other hand, comprises osteoconductive bioceramic beads capable of being vacuum-loaded with antibiotics or other liquid medications, allowing for sustained drug delivery lasting over 30 days. These innovations mark a substantial advancement in targeted treatment for bone infections and regeneration, showcasing the potential of pharma-grade calcium sulphate in developing future biomedical solutions that comply with strict global benchmarks.

Who Are The Firms Contributing To The Pharma Grade Calcium Sulphate Market Ecosystem?

Major companies operating in the pharma grade calcium sulphate market are Thermo Fisher Scientific Inc., Merck KGaA, Honeywell International Inc., Avantor Inc., Spectrum Chemical Manufacturing Corp., MP Biomedicals LLC, Anhui Sunhere Pharmaceutical Excipients, Huzhou Zhanwang Pharmaceutical Co. Ltd., Loba Chemie Pvt. Ltd., SRL Chemical, GFS Chemicals Inc., American Elements, Junsei Chemical Co. Ltd., Tokyo Chemical Industry Co. Ltd., Fagron N.V., Mallinckrodt Pharmaceuticals, Ashland Global Holdings Inc., JRS Pharma, DFE Pharma, Roquette Frères

Access The Complete Pharma Grade Calcium Sulphate Market Report:

https://www.thebusinessresearchcompany.com/report/pharma-grade-calcium-sulphate-global-market-report

Which Area Represents The Largest Portion Of The Pharma Grade Calcium Sulphate Market?

North America was the largest region in the pharma grade calcium sulphate market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharma grade calcium sulphate market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Pharma Grade Calcium Sulphate Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=24372&type=smp

Browse Through More Reports Similar to the Global Pharma Grade Calcium Sulphate Market 2026, By The Business Research Company

Potassium Sulphate Market Report 2026

https://www.thebusinessresearchcompany.com/report/potassium-sulphate-global-market-report

Calcium Aluminosilicate Market Report 2026

https://www.thebusinessresearchcompany.com/report/calcium-aluminosilicate-global-market-report

Calcium Nitrate Market Report 2026

https://www.thebusinessresearchcompany.com/report/calcium-nitrate-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795